skip to main content

H.R. 5020 (114th): Synthetic Drug Awareness Act of 2016


The text of the bill below is as of Apr 21, 2016 (Introduced). The bill was not enacted into law.


I

114th CONGRESS

2d Session

H. R. 5020

IN THE HOUSE OF REPRESENTATIVES

April 21, 2016

(for himself, Mr. Gowdy, Mr. Collins of New York, and Mr. Butterfield) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To require the Surgeon General of the Public Health Service to submit to Congress a report on the effects on public health of the increased rate of use of synthetic drugs.

1.

Short title

This Act may be cited as the Synthetic Drug Awareness Act of 2016.

2.

Report on effects on public health of synthetic drug use

(a)

In general

Not later than three years after the date of the enactment of this Act, the Surgeon General of the Public Health Service shall submit to Congress a report on the effects on public health of the increase since January 2010 in the rate of use of synthetic drugs in the United States by individuals who are at least 12 years of age but not more than 18 years of age.

(b)

Synthetic drug defined

For purposes of subsection (a), the term synthetic drug means a drug which is developed and manufactured to avoid control under the Controlled Substances Act (21 U.S.C. 801 et seq.).